Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.28 USD | +0.56% | +0.73% | -1.23% |
Apr. 18 | Land & Buildings Issues Letter to Shareholders of National Health Investors | CI |
Feb. 16 | National HealthCare's Q4 Adjusted Earnings, Revenue Increase | MT |
Financials (USD)
Sales 2022 | 1.07B | Sales 2023 | 1.14B | Capitalization | 1.42B |
---|---|---|---|---|---|
Net income 2022 | 22M | Net income 2023 | 66M | EV / Sales 2022 | 0.8 x |
Net cash position 2022 | 56.65M | Net cash position 2023 | 130M | EV / Sales 2023 | 1.13 x |
P/E ratio 2022 |
41
x | P/E ratio 2023 |
21.3
x | Employees | 13,123 |
Yield 2022 |
3.8% | Yield 2023 |
2.53% | Free-Float | 80.41% |
1 day | +0.56% | ||
1 week | +0.73% | ||
Current month | -3.42% | ||
1 month | -0.32% | ||
3 months | -6.62% | ||
6 months | +36.95% | ||
Current year | -1.23% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Flatt
CEO | Chief Executive Officer | 68 | 05-05-31 |
Brian Kidd
DFI | Director of Finance/CFO | 49 | 07-12-31 |
Robert Ussery
PSD | President | 65 | 79-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Adams
CHM | Chairman | 77 | 90-12-31 |
W. Adams
BRD | Director/Board Member | 78 | 73-12-31 |
Richard LaRoche
BRD | Director/Board Member | 78 | 01-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.31% | 29 M€ | -4.33% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 91.28 | +0.56% | 29,397 |
24-04-25 | 90.77 | -0.40% | 37,406 |
24-04-24 | 91.13 | -0.05% | 37,688 |
24-04-23 | 91.18 | +1.32% | 35,848 |
24-04-22 | 89.99 | -0.70% | 41,974 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-1.23% | 1.41B | |
-24.26% | 2.18B | |
-26.82% | 1.37B | |
+19.59% | 1.32B | |
+15.23% | 706M | |
-2.73% | 464M | |
+240.37% | 432M | |
-7.77% | 322M | |
+1.24% | 124M | |
+39.04% | 88.82M |
- Stock Market
- Equities
- NHC Stock